Ijpo 3 (3) 479-484
Ijpo 3 (3) 479-484
Ijpo 3 (3) 479-484
*Corresponding Author:
Email: [email protected]
Abstract
Background and Objectives: Pancytopenia is one of the most common indications for bone marrow (BM) examination. There
are spectrums of condition involving the bone marrow (BM) that can present with pancytopenia and include malignant as well as
benign diseases. The objective of this study is to evaluate the BM findings in cases of pancytopenia.
Materials and Methods: This was a retrospective study of 156 cases of pancytopenia presenting over a period of 3 years. Data
were retrieved from laboratory and clinical records and were analysed.
Results: Out of 156 cases, the most common cause for pancytopenia in this study was megaloblastic anemia (25.6%), followed
by acute leukemia (16%), hypoplastic marrow (14%), metastatic solid tumors (8.9%), myelodysplastic syndrome (MDS) (7.1%),
lymphomas (5.7%), plasma cell dyscrasia(3.8%). Along with these there were many benign yet rare causes which may present
with pancytopenia like Hemophagocytic syndrome (1.2%), Histoplasmosis (0.6%), Leishmaniasis (0.6%) and Gaucher’s disease
(0.6%). Bone marrow examination (combining both aspirate and biopsy) alone was sufficient in diagnosing 55% of cases, while
remaining cases require additional details like clinical findings (for cases of MDS, viral infection, hypersplenism, autoimmune,
septicemia) and special investigations like hemoglobin electrophoresis for hemoglobinopathy. In only 3.8% cases, BME was
inconclusive.
Conclusion: BME is an important investigation in diagnostic work up of cases of pancytopenia. In majority of cases, it can
provide an accurate diagnosis or at least can guide the approach towards diagnosis and management. Thus, it should be
performed in all cases of persistent pancytopenia and should be evaluated in light of clinical details and supportive investigations.
Access this article online Bone marrow examination not only helps in final
Quick Response diagnosis but can also help in indicating the approach to
Code: Website: diagnosis based on various parameters like cellularity
www.innovativepublication.com (hypocellular or hypercellular), Blasts (for leukemias),
abnormal cells (lymphoma, plasma cells, carcinoma
cells, histiocytes), organisms (fungus, parasite),
DOI: dysplastic changes in cells (MDS) or megaloblastic
10.5958/2394-6792.2016.00089.2 maturation.
Correlation with bone marrow biopsy is also
important in cases where aspirate is hemodiluted or in
Introduction hypocellular marrows. Biopsy also helps in many
Pancytopenia is an important clinical entity which conditions which focally involve the bone marrow like
is defined as reduction in the number of all the three metastatic carcinomas or lymphomas or tuberculosis.
series (WBC’s, RBC’s and platelets) in peripheral This study is performed at a tertiary care centre and
blood1. medical college in India and is intended to look at BM
Pancytopenia is a clinical outcome of many findings in cases of pancytopenia so that one should
diseases that involve bone marrow either primarily or keep in mind various differentials that can present with
secondarily. Management of pancytopenia cases pancytopenia.
depends on the severity of pancytopenia and treatment
of the underlying pathology2. Materials and Methods
There are various mechanisms for development of This was a retrospective study performed at a
pancytopenia and this include reduced or ineffective tertiary care centre and medical college over a period of
hematopoiesis and increased destruction by either three years in Department of pathology. Laboratory
sequestration or destruction by antibodies3. data from all the cases who presented with
In cases of pancytopenias, patient usually presents pancytopenia (hemoglobin< 10gm/dl total leukocyte
with clinical features attributable to decreased number count < 4000/mm3 and platelet count /150,000/mm3)
of RBC’s, platelets or WBC’s i.e., pallor, easy were retrieved. Clinical details were obtained from
fatiguability, bleeding, weight loss, or repeated patient’s case file and was tabulated, analyzed and
infections leading to fever4. correlated with that of laboratory parameters. Cases of
Indian Journal of Pathology and Oncology, July-September 2016;3(3);479-484 479
Sandeep Ojha et al. Bone marrow examination findings in cases of pancytopenia- a study from central India
chemotherapy induced pancytopenia (whether benign ranged from 2 months to 70 years. Out of 156 cases of
or malignant) were excluded from this study. Bone pancytopenia, 41 patients (26.3%) were in pediatric age
marrow aspiration was performed from posterior group (<18 years) and remaining 115 patients (73.7%)
superior iliac spine. Slides were prepared and stained were adults (>18 years).
with leishman stain. Biopsy was processed as per Most common presentation (Table 2) was pallor
laboratory protocol for bone marrow. Special stains (70.5%) followed by fever (30.1%), splenomegaly
were performed wherever required. (23.1%), hepatomegaly (19.8%) and associated
lymphadenopathy (17.3%) while only 5.7% cases were
Results asymptomatic.
In our institute we receive a total of 610 bone Peripheral smear findings (Table 3) in most of the
marrow specimens over 3 year duration of which we cases show presence of anisocytosis (41%) followed by
studied around 156 cases who presented with lymphocytosis (32.1%), nucleated red blood cells
pancytopenia (Table 1). Male: female ratio was 1.6:1 (31.4%), and poikilocytosis (20.5%). Blasts were seen
with 97 males and 59 females. The age of the patients in 15.4% cases.
Viral (3) 0 3 0 2 0 0 0
Hypersplenism(3 3 0 0 0 3 0 0
)
Autoimmune 3 1 0 0 0 0 0
(ITP, SLE) (3)
Hairy cell 2 0 0 1 2 0 0
leukemia (2)
Haemophagocyti 2 2 0 0 2 1 0
c syndrome(2)
Myelofibrosis(2) 2 1 0 0 2 2 0
Septicemia (2) 0 2 0 0 0 0 0
Leishmaniasis 0 1 0 0 1 1 0
(1)
Histoplasmosis( 1 1 0 1 1 0 0
1)
Malaria (1) 1 1 0 0 1 0 0
Gauchers 1 0 0 1 1 1 0
Disease (1)
Tuberculosis (1) 0 1 0 1 0 0 0
Hemoglobinopat 1 0 0 0 0 0 0
hy (1)
Inconclusive (6) 1 2 0 0 1 0 3
Total (156) 110 47(30. 4 (2.5%) 27 (17.3%) 36 (23.1%) 31 (19.8%) 9
(70.5 1%) (5.7%)
%)
Hemoglobinopathy (1) 1 1 0 0 0
Inconclusive (6) 1 0 1 0 1
Total (156) 64 (41%) 32 (20.5%) 49 (31.4%) 24 50 (32.1%)
(15.4%)
Fig. 1: Smears showing clusters of small round cells Fig. 4: Scattered and intra-cytoplasmic parasite
in a known case of small cell carcinoma (BM, 400x) consistent with leishmaniasis (BM, 1000x)
infections) should be kept in mind as some of them can lymphohistiocytosis. Pediatr Blood Cancer. 2007;48
be life threatening. Correlation of clinical, peripheral (2):124-131.
smear finding and bone marrow aspirate findings are
required to arrive at final diagnosis.
References
1. Ishtiaq O, Baqai HZ, Anwer F, Hussain N J. Patterns of
pancytopenia patients in a general medical ward and a
proposed diagnostic approach. Journal of Ayub Med Coll
Abbottabad. 2004 Jan-Mar;16(1):8-13.
2. Tilak V, Jain R. Pancytopenia--a clinico-hematologic
analysis of 77 cases. Indian J Pathol Microbiol. 1999
Oct;42(4):399-404.
3. Williams MD. Pancytopenia, aplastic anemia and pure
red cell aplasia. In: Lee RG, Foerster J, Lukens J,
Paraskevas F, Greer JP, Rodgers GM, (eds). Wintrobe’s
Clinical Haematology 10th edn. Williams and Wilkins;
1997. pp1449-76.
4. Santra G, Das BK. A cross-sectional study of the clinical
profile and aetiological spectrum of pancytopenia in a
tertiary care centre. Singapore Med J. 2010
Oct;51(10):806-12.
5. Pathak R, Jha A, Sayami G. Evaluation of bone marrow
in patients with pancytopenia. Journal of Pathology of
Nepal 2012;2:265 -71.
6. Jha A, Sayami G, Adhikari RC, Panta AD, Jha R. Bone
Marrow Examination in Cases of Pancytopenia. J Nepal
Med Assoc. 2008;47:12-7.
7. Bashawri LA. Bone marrow examination. Indications and
diagnostic value. Saudi Med J 2002;23:191-6.
8. Das Makheja K, Kumar Maheshwari B, Arain S, Kumar
S, Kumari S, Vikash. The common causes leading to
pancytopenia in patients presenting to tertiary care
hospital. Pak J Med Sci. 2013;29:1108–11.
9. Aziz T, Liaquat Ali L, Ansari T, Liaquat HB, Shah S,
Jamal AJ. Pancytopenia: Megaloblastic anemia is still the
commonest cause. Pak J Med Sci. 2010;26:1132-6.
10. Khunger JM, Arulselvi S, Sharma U, Ranga S, Talib VH.
Pancytopenia – A clinico haematological study of 200
cases. Indian J Pathol Microbiol. 2002;45:375–9.
11. Khodke K, Marwah S, Buxi G, Vadav RB, Chaturvedi
NK. Bone marrow examination in cases of
pancytopenia. J Acad Clin Med. 2001;2:55–9.
12. Tilak V, Jain R. Pancytopenia – A clinico-hematologic
analysis of 77 cases. Indian J Pathol Microbiol.1999;42:
399–404.
13. Gayathri BN, Rao KS. Pancytopenia: A clinico
hematological study. J Lab Physicians. 2011;3:15–20.
14. Kumar R, Kalra SP, Kumar H, Anand AC, Madan H.
Pancytopenia – A six year study. J Assoc Physicians
India. 2001;49:1078–81.
15. Dasgupta S, Mandal PK, Chakrabarti S. Etiology of
Pancytopenia: An observation from a referral medical
institution of Eastern Region of India . J Lab Physicians.
2015;7:90-5.
16. Hossain MA, Akond AK, Chowdhary MK, Sikder AM,
Rashid MA, “Pancytopenia-A study of 50 cases”,
Bangladesh Journal of Pathology. 1992;1:9-12.
17. Keisu M, Ost A. Diagnosis in patients with severe
pancytopenia suspected of having aplastic anemia. Eur J
Haematol. 1990;45:11-4.
18. Henter JI1, Horne A, Aricó M, Egeler RM, Filipovich
AH, Imashuku S, Ladisch S, McClain K, Webb
D, Winiarski J, Janka G. HLH-2004: diagnostic and
therapeutic guidelines for hemophagocytic
Indian Journal of Pathology and Oncology, July-September 2016;3(3);479-484 484